Skip to content Skip to footer

Research Portal of the TU Dresden

Trillium-Krebsmedizin

ISSNs: 2198-9818

Trillium GmbH, Grafrath, Germany

Journal

1 - 1 out of 1Page size: 10

Select page size:

Sort by: Publication date

Sort by:

Order:

Asc.

Desc.

1 Research output

Operables Melanom: Neoadjuvante Immuntherapie – eine vielversprechende Option
Gellrich, F. F., 4 Jun 2024, In: Trillium-Krebsmedizin. 33, 3, p. 192-197 6 p.
Research output: Contribution to journal › Research article › Contributed
Published